Research and Markets has announced the addition of the "Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets" report to their offering.
The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015. This market is expected to grow from nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021.
The report provides a brief overview of the gastrointestinal system, which provides an introduction to the disorders of the gastrointestinal system; cites risk factors, where applicable; presents current pharmaceutical treatments, market size and key market participants (both prescription and OTC); and presents potential treatments in R&D, potential market size and future market entrants.
Scope of the Report:
- An overview of the global markets for gastrointestinal therapeutics and diagnostics.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
- Analyses of therapeutics currently on the market as well as potential products and classes of products that are likely to have a significant impact.
- Descriptions of the industry in detail, its relationship to the healthcare industry, its participants, and its trends for the future.
- Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities.
- Profiles of major players in the industry.
Companies Mentioned:
- Allergan Plc
- Ardelyx Inc.
- Astellas Pharma Inc.
- AstraZeneca
- Celgene Corp.
- Clovis Oncology
- Daewoong Pharmaceutical Co. Ltd.
- Eli Lilly and Company
- GlaxoSmithKline
- Horizon Pharma Plc
- ImmunogenX
- Immunomedics
- Merck Co.
- Merrimack Pharmaceuticals Inc.
- New Link Genetics
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
- Roche
- Sanofi
- Shire
- Sucampo Pharmaceuticals Inc.
- Synergy Pharmaceuticals Inc.
- Synthetic Biologics
- Taiho Pharmaceutical Co. Ltd.
- Takeda Pharmaceuticals
- Valeant Pharmaceuticals
Key Topics Covered:
1: Introduction Complimentary
2: Executive Summary
3: Overview
4: Etiology
5: Prescription Therapy Market
6: OTC Therapy Market
7: Diagnostics And Devices Market
8: Gastrointestinal Product Pipeline
9: Patents
10: Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/l5lhfx/gastrointestinal.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161006006265/en/
Contacts:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics, Gastrointestinal Drugs